Diagnosis (Laboratory)

(Unterschied zwischen Versionen)
Wechseln zu: Navigation, Suche
Zeile 4: Zeile 4:
 
*'''[[Dx Antigen]]'''
 
*'''[[Dx Antigen]]'''
 
*'''[[Dx Antibodies]]'''
 
*'''[[Dx Antibodies]]'''
 +
*'''[[Dx Serology]]]''' all the imbecile titles not showing what they intend to test
 
*'''[[Dx various methods]]'''
 
*'''[[Dx various methods]]'''
*''*[[Dx which matrix]]
+
*'''*[[Dx which matrix]]'''
 +
 
 +
 
 +
 
  
'''Diagnosing Covid by pcr, antibodies and so on'''
 
  
  
{{tp|p=32490723|t=2020. Development of a TaqMan-probe-based multiplex real-time PCR for the simultaneous detection of emerging and reemerging swine coronaviruses.|pdf=|usr=007}}
 
{{tp|p=32428207|t=2020. Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.|pdf=|usr=007}}
 
 
{{tp|p=32282894|t=ä. Diagnostic Testing for Severe Acute Respiratory Syndrome?Related Coronavirus-2: A Narrative Review |pdf=|usr=}}
 
{{tp|p=32282894|t=ä. Diagnostic Testing for Severe Acute Respiratory Syndrome?Related Coronavirus-2: A Narrative Review |pdf=|usr=}}
 
*[https://archive.fo/61OpY on false-positives]
 
*[https://archive.fo/61OpY on false-positives]
 
*[https://www.aljazeera.com/news/2020/05/tanzania-covid-19-lab-head-suspended-president-questions-data-200505065136872.html on positives in non-vertebrate samples]
 
*[https://www.aljazeera.com/news/2020/05/tanzania-covid-19-lab-head-suspended-president-questions-data-200505065136872.html on positives in non-vertebrate samples]
*[https://www.wsj.com/articles/roche-coronavirus-antibody-test-wins-fda-approval-for-emergency-use-11588505019 antibody test roche]
+
 
 
{{tp|p=32293168|t=ä. Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal  Swab Specimens Using Field-Effect Transistor-Based Biosensor |pdf=|usr=}}
 
{{tp|p=32293168|t=ä. Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal  Swab Specimens Using Field-Effect Transistor-Based Biosensor |pdf=|usr=}}
 
{{tp|p=32223179|t=ä. Diagnosing COVID-19: The Disease and Tools for Detection |pdf=|usr=}}
 
{{tp|p=32223179|t=ä. Diagnosing COVID-19: The Disease and Tools for Detection |pdf=|usr=}}
 
{{tp|p=32281785|t=ä. Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection |pdf=|usr=}}
 
{{tp|p=32281785|t=ä. Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection |pdf=|usr=}}
{{tp|p=32320384|t=2020. Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19 |pdf=|usr=}}
+
 
 
{{tp|p=32304208|t=ä. Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources |pdf=|usr=}}
 
{{tp|p=32304208|t=ä. Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources |pdf=|usr=}}
 
{{tp|p=32227199|t=ä. SARS-CoV-2 Testing: Trials and Tribulations |pdf=|usr=}}
 
{{tp|p=32227199|t=ä. SARS-CoV-2 Testing: Trials and Tribulations |pdf=|usr=}}
{{tp|p=32323974|t=ä. Rapid and Sensitive Detection of anti-SARS-CoV-2 IgG, Using Lanthanide-Doped Nanoparticles-Based Lateral Flow Immunoassay |pdf=|usr=}}
+
 
 
{{tp|p=Cä|t=Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea.|pdf=http://europepmc.org/articles/PMC7169629?pdf=render|usr=}}
 
{{tp|p=Cä|t=Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea.|pdf=http://europepmc.org/articles/PMC7169629?pdf=render|usr=}}
 
{{tp|p=32259132|t=2020. Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study  |pdf=|usr=}}
 
{{tp|p=32259132|t=2020. Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study  |pdf=|usr=}}
Zeile 42: Zeile 43:
 
{{tp|p=32031583|t=ä. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia |pdf=|usr=}}
 
{{tp|p=32031583|t=ä. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia |pdf=|usr=}}
 
{{tp|p=32156607|t=ä. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one  hospital in Wuhan, China, from Jan to Feb 2020 |pdf=|usr=}}
 
{{tp|p=32156607|t=ä. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one  hospital in Wuhan, China, from Jan to Feb 2020 |pdf=|usr=}}
{{tp|p=32343948|t=2020. IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A  longitudinal study |pdf=|usr=}}
+
 
 
{{tp|p=32335089|t=ä. Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories |pdf=|usr=}}
 
{{tp|p=32335089|t=ä. Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories |pdf=|usr=}}
 
{{tp|p=32315614|t=2020. Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients |pdf=|usr=}}
 
{{tp|p=32315614|t=2020. Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients |pdf=|usr=}}
 
{{tp|p=32295319|t=2020. Innovative screening tests for COVID-19 in South Korea |pdf=|usr=}}
 
{{tp|p=32295319|t=2020. Innovative screening tests for COVID-19 in South Korea |pdf=|usr=}}
 
{{tp|p=32358960|t=ä. Evaluation of COVID-19 RT-qPCR test in multi-sample pools |pdf=|usr=}}
 
{{tp|p=32358960|t=ä. Evaluation of COVID-19 RT-qPCR test in multi-sample pools |pdf=|usr=}}
{{tp|p=32357209|t=ä. Early detection of SARS-CoV-2 antibodies in COVID-19 patients as a serologic marker of infection |pdf=|usr=}}
+
 
 
{{tp|p=32357206|t=ä. Role of serology in the COVID-19 pandemic |pdf=|usr=}}
 
{{tp|p=32357206|t=ä. Role of serology in the COVID-19 pandemic |pdf=|usr=}}
 
{{tp|p=32221523|t=ä. Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients |pdf=|usr=}}
 
{{tp|p=32221523|t=ä. Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients |pdf=|usr=}}
{{tp|p=32221519|t=ä. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 |pdf=|usr=}}
+
 
 
{{tp|p=32047895|t=ä. Consistent Detection of 2019 Novel Coronavirus in Saliva |pdf=|usr=}}
 
{{tp|p=32047895|t=ä. Consistent Detection of 2019 Novel Coronavirus in Saliva |pdf=|usr=}}
 
{{tp|p=32271374|t=ä. Effect of throat washings on detection of 2019 novel coronavirus |pdf=|usr=}}
 
{{tp|p=32271374|t=ä. Effect of throat washings on detection of 2019 novel coronavirus |pdf=|usr=}}
{{tp|p=32337590|t=ä. Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |pdf=|usr=}}
+
 
 
{{tp|p=32241023|t=ä. Gargle lavage as a safe and sensitive alternative to swab samples to diagnose COVID-19: a case report in Japan |pdf=|usr=}}
 
{{tp|p=32241023|t=ä. Gargle lavage as a safe and sensitive alternative to swab samples to diagnose COVID-19: a case report in Japan |pdf=|usr=}}
{{tp|p=32306047|t=ä. Antibody Detection and Dynamic Characteristics in Patients with COVID-19 |pdf=|usr=}}
+
 
 
{{tp|p=32306042|t=ä. Testing for SARS-CoV-2: Can We Stop at Two?|pdf=|usr=}}
 
{{tp|p=32306042|t=ä. Testing for SARS-CoV-2: Can We Stop at Two?|pdf=|usr=}}
 
{{tp|p=32276116|t=ä. Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay |pdf=|usr=}}
 
{{tp|p=32276116|t=ä. Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay |pdf=|usr=}}
Zeile 68: Zeile 69:
 
{{tp|p=32244841|t=2020. Blockchain and Artificial Intelligence Technology for Novel Coronavirus Disease-19 Self-Testing |pdf=|usr=}}
 
{{tp|p=32244841|t=2020. Blockchain and Artificial Intelligence Technology for Novel Coronavirus Disease-19 Self-Testing |pdf=|usr=}}
  
{{tp|p=32267220|t=2020. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients |pdf=|usr=}}
+
 
 
{{tp|p=32294051|t=2020. Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2 |pdf=|usr=}}
 
{{tp|p=32294051|t=2020. Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2 |pdf=|usr=}}
 
{{tp|p=32273299|t=2020. Self-screening to reduce medical resource consumption facing the COVID-19 pandemic |pdf=|usr=}}
 
{{tp|p=32273299|t=2020. Self-screening to reduce medical resource consumption facing the COVID-19 pandemic |pdf=|usr=}}
{{tp|p=32357808|t=2020. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients |pdf=|usr=}}
+
 
 
{{tp|p=32306864|t=2020. Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients |pdf=|usr=}}
 
{{tp|p=32306864|t=2020. Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients |pdf=|usr=}}
 
{{tp|p=32196430|t=2020. Laboratory diagnosis of emerging human coronavirus infections - the state of the  art |pdf=|usr=}}
 
{{tp|p=32196430|t=2020. Laboratory diagnosis of emerging human coronavirus infections - the state of the  art |pdf=|usr=}}
Zeile 99: Zeile 100:
 
{{tp|p=32242876|t=2020. Development of in vitro transcribed RNA as positive control for laboratory diagnosis of SARS-CoV-2 in India |pdf=|usr=}}
 
{{tp|p=32242876|t=2020. Development of in vitro transcribed RNA as positive control for laboratory diagnosis of SARS-CoV-2 in India |pdf=|usr=}}
 
{{tp|p=32342674|t=2020. Glove-Wall System for Respiratory Specimen Collection and COVID-19 Mass Screening |pdf=|usr=}}
 
{{tp|p=32342674|t=2020. Glove-Wall System for Respiratory Specimen Collection and COVID-19 Mass Screening |pdf=|usr=}}
{{tp|p=32363011|t=2020. Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2 |pdf=|usr=}}
+
 
 
{{tp|p=32007627|t=2020. Novel coronavirus: From discovery to clinical diagnostics |pdf=|usr=}}
 
{{tp|p=32007627|t=2020. Novel coronavirus: From discovery to clinical diagnostics |pdf=|usr=}}
 
{{tp|p=32304994|t=ä. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients |pdf=|usr=}}
 
{{tp|p=32304994|t=ä. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients |pdf=|usr=}}
Zeile 118: Zeile 119:
 
{{tp|p=32269100|t=2020. Comparative Performance of SARS-CoV-2 Detection Assays using Seven Different Primer/Probe Sets and One Assay Kit |pdf=|usr=}}
 
{{tp|p=32269100|t=2020. Comparative Performance of SARS-CoV-2 Detection Assays using Seven Different Primer/Probe Sets and One Assay Kit |pdf=|usr=}}
 
{{tp|p=32350048|t=2020. Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories |pdf=|usr=}}
 
{{tp|p=32350048|t=2020. Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories |pdf=|usr=}}
{{tp|p=32350047|t=2020. The Role of Antibody Testing for SARS-CoV-2: Is There One?|pdf=|usr=}}
+
 
 
{{tp|p=32341143|t=2020. Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens |pdf=|usr=}}
 
{{tp|p=32341143|t=2020. Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens |pdf=|usr=}}
 
{{tp|p=32341142|t=2020. Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection |pdf=|usr=}}
 
{{tp|p=32341142|t=2020. Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection |pdf=|usr=}}
Zeile 131: Zeile 132:
 
{{tp|p=32303564|t=2020. Comparison of Abbott ID Now, Diasorin Simplexa, and CDC FDA EUA methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19 |pdf=|usr=}}
 
{{tp|p=32303564|t=2020. Comparison of Abbott ID Now, Diasorin Simplexa, and CDC FDA EUA methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19 |pdf=|usr=}}
 
{{tp|p=32295896|t=2020. Nasal swab sampling for SARS-CoV-2: A convenient alternative in time of nasopharyngeal swab shortage |pdf=|usr=}}
 
{{tp|p=32295896|t=2020. Nasal swab sampling for SARS-CoV-2: A convenient alternative in time of nasopharyngeal swab shortage |pdf=|usr=}}
{{tp|p=32277023|t=2020. A method to prevent SARS-CoV-2 IgM false positives in gold immunochromatography and enzyme-linked immunosorbent assays |pdf=|usr=}}
+
 
 
{{tp|p=32277022|t=2020. Clinical evaluation of the cobas SARS-CoV-2 test and a diagnostic platform switch during 48 hours in the midst of the COVID-19 pandemic |pdf=|usr=}}
 
{{tp|p=32277022|t=2020. Clinical evaluation of the cobas SARS-CoV-2 test and a diagnostic platform switch during 48 hours in the midst of the COVID-19 pandemic |pdf=|usr=}}
 
{{tp|p=32361322|t=2020. Interpret with caution: An evaluation of the commercial AusDiagnostics versus in-house developed assays for the detection of SARS-CoV-2 virus |pdf=|usr=}}
 
{{tp|p=32361322|t=2020. Interpret with caution: An evaluation of the commercial AusDiagnostics versus in-house developed assays for the detection of SARS-CoV-2 virus |pdf=|usr=}}
Zeile 138: Zeile 139:
 
{{tp|p=32328218|t=ä. Salivary diagnostics in COVID-19: Future research implications |pdf=|usr=}}
 
{{tp|p=32328218|t=ä. Salivary diagnostics in COVID-19: Future research implications |pdf=|usr=}}
  
{{tp|p=32209385|t=ä. Profile of specific antibodies to SARS-CoV-2: The first report |pdf=|usr=}}
+
 
 
{{tp|p=32360885|t=ä. Value and Challenges: Nucleic Acid Amplification Tests for SARS?CoV-2 in Hospitalized COVID-19 Patients |pdf=|usr=}}
 
{{tp|p=32360885|t=ä. Value and Challenges: Nucleic Acid Amplification Tests for SARS?CoV-2 in Hospitalized COVID-19 Patients |pdf=|usr=}}
{{tp|p=32335175|t=ä. Reliability and usefulness of a rapid IgM?IgG antibody test for the diagnosis of  SARS-CoV-2 infection: a preliminary report |pdf=|usr=}}
 
{{tp|p=32335168|t=ä. Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients |pdf=|usr=}}
 
 
{{tp|p=32298676|t=ä. Saliva is a reliable tool to detect SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32298676|t=ä. Saliva is a reliable tool to detect SARS-CoV-2 |pdf=|usr=}}
  
Zeile 171: Zeile 170:
  
 
{{tp|p=C7187661|t=ä. Group Testing for SARS-CoV-2: Forward to the Past?|pdf=|usr=}}
 
{{tp|p=C7187661|t=ä. Group Testing for SARS-CoV-2: Forward to the Past?|pdf=|usr=}}
{{tp|p=32329979|t=2020. COVID-19 rapid antibody cassette point of care tests: practical considerations |pdf=|usr=}}
+
 
 
{{ttp|p=32358057|t=2020. Overcoming the bottleneck to widespread testing: A rapid review of nucleic acid testing approaches for COVID-19 detection |pdf=|usr=}}
 
{{ttp|p=32358057|t=2020. Overcoming the bottleneck to widespread testing: A rapid review of nucleic acid testing approaches for COVID-19 detection |pdf=|usr=}}
 
{{ttp|p=32373393|t=ä. Rapid and Sensitive Detection of COVID-19 Using CRISPR/Cas12a-based Detection with Naked Eye Readout, CRISPR/Cas12a-NER |pdf=|usr=}}
 
{{ttp|p=32373393|t=ä. Rapid and Sensitive Detection of COVID-19 Using CRISPR/Cas12a-based Detection with Naked Eye Readout, CRISPR/Cas12a-NER |pdf=|usr=}}
Zeile 193: Zeile 192:
 
{{tp|p=32242831|t=2020. Clinical laboratory and SARS-CoV-2 infection: where do we stand?|pdf=|usr=}}
 
{{tp|p=32242831|t=2020. Clinical laboratory and SARS-CoV-2 infection: where do we stand?|pdf=|usr=}}
 
{{tp|p=32242829|t=2020. One disease, different features: COVID-19 laboratory and radiological findings in three Italian patients |pdf=|usr=}}
 
{{tp|p=32242829|t=2020. One disease, different features: COVID-19 laboratory and radiological findings in three Italian patients |pdf=|usr=}}
{{tp|p=32301750|t=2020. Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays |pdf=|usr=}}
+
 
{{tp|p=32301749|t=2020. Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics |pdf=|usr=}}
+
 
 
{{tp|p=32301748|t=2020. Clinical chemistry tests for patients with COVID-19 - important caveats for interpretation |pdf=|usr=}}
 
{{tp|p=32301748|t=2020. Clinical chemistry tests for patients with COVID-19 - important caveats for interpretation |pdf=|usr=}}
 
{{tp|p=32301745|t=2020. Comparison of throat swabs and sputum specimens for viral nucleic acid detection  in 52 cases of novel coronavirus (SARS-Cov-2)-infected pneumonia (COVID-19) |pdf=|usr=}}
 
{{tp|p=32301745|t=2020. Comparison of throat swabs and sputum specimens for viral nucleic acid detection  in 52 cases of novel coronavirus (SARS-Cov-2)-infected pneumonia (COVID-19) |pdf=|usr=}}
Zeile 212: Zeile 211:
 
{{tp|p=32349033|t=2020. Novel biosensor platforms for the detection of coronavirus infection and SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32349033|t=2020. Novel biosensor platforms for the detection of coronavirus infection and SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32366669|t=2020. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test |pdf=|usr=}}
 
{{tp|p=32366669|t=2020. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test |pdf=|usr=}}
{{tp|p=32229605|t=2020. Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2 |pdf=|usr=}}
 
  
{{tp|p=32227490|t=ä. Performance of VivaDiag COVID?19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID?19 in acute patients referring to emergency room department |pdf=|usr=}}
+
 
 +
 
 
{{tp|p=32222993|t=ä. Genomic characterization and phylogenetic analysis of SARS?COV?2 in Italy |pdf=|usr=}}
 
{{tp|p=32222993|t=ä. Genomic characterization and phylogenetic analysis of SARS?COV?2 in Italy |pdf=|usr=}}
{{tp|p=32104917|t=ä. Development and clinical application of a rapid IgM?IgG combined antibody test for SARS?CoV?2 infection diagnosis |pdf=|usr=}}
+
 
 
{{tp|p=32096564|t=ä. Combination of RT?qPCR testing and clinical features for diagnosis of COVID?19 facilitates management of SARS?CoV?2 outbreak |pdf=|usr=}}
 
{{tp|p=32096564|t=ä. Combination of RT?qPCR testing and clinical features for diagnosis of COVID?19 facilitates management of SARS?CoV?2 outbreak |pdf=|usr=}}
{{tp|p=32243608|t=ä. Detection of antibodies against SARS?CoV?2 in patients with COVID?19 |pdf=|usr=}}
+
 
 
{{tp|p=32270882|t=2020. False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence |pdf=|usr=}}
 
{{tp|p=32270882|t=2020. False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence |pdf=|usr=}}
{{tp|p=32347966|t=2020. An Evolving Approach to the Laboratory Assessment of COVID-19 |pdf=|usr=}}
+
{{tp|p=32347966|t=2020. An Evolving Approach to the Laboratory Assessment of COVID-19 |pdf=|usr
{{tp|p=32330303|t=2020. Characteristics of patients with coronavirus disease (COVID-19) confirmed using an IgM-IgG antibody test |pdf=|usr=}}
+
{{tp|p=32330291|t=2020. Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience |pdf=|usr=}}
+
{{tp|p=32320064|t=2020. Evaluation of the auxiliary diagnostic value of antibody assays for the detection of novel coronavirus (SARS-CoV-2) |pdf=|usr=}}
+
 
{{tp|p=32311142|t=2020. Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection  in Wuhan, China |pdf=|usr=}}
 
{{tp|p=32311142|t=2020. Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection  in Wuhan, China |pdf=|usr=}}
 
{{ttp|p=32297981|t=2020. COVID-19: Recommended sampling sites at different stage of the disease |pdf=|usr=}}
 
{{ttp|p=32297981|t=2020. COVID-19: Recommended sampling sites at different stage of the disease |pdf=|usr=}}
Zeile 230: Zeile 226:
 
{{ttp|p=32374370|t=2020. Interpreting Diagnostic Tests for SARS-CoV-2 |pdf=|usr=}}
 
{{ttp|p=32374370|t=2020. Interpreting Diagnostic Tests for SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32367861|t=2020. Bronchoalveolar specimen can help detect COVID-19 in suspicious case with negative PCR for nasopharyngeal specimen test |pdf=|usr=}}
 
{{tp|p=32367861|t=2020. Bronchoalveolar specimen can help detect COVID-19 in suspicious case with negative PCR for nasopharyngeal specimen test |pdf=|usr=}}
{{tp|p=32301958|t=2020. The Promise and Peril of Antibody Testing for COVID-19 |pdf=|usr=}}
+
 
 
{{tp|p=32236503|t=2020. Testing Individuals for Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
 
{{tp|p=32236503|t=2020. Testing Individuals for Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
 
{{tp|p=32334422|t=2020. Smartphone-based multiplex 30-minute nucleic acid test of live virus from nasal swab extract |pdf=|usr=}}
 
{{tp|p=32334422|t=2020. Smartphone-based multiplex 30-minute nucleic acid test of live virus from nasal swab extract |pdf=|usr=}}
{{tp|p=32247384|t=2020. Developing antibody tests for SARS-CoV-2 |pdf=|usr=}}
+
 
 
{{tp|p=32171389|t=2020. SARS-CoV-2 RNA more readily detected in induced sputum than in throat swabs of convalescent COVID-19 patients |pdf=|usr=}}
 
{{tp|p=32171389|t=2020. SARS-CoV-2 RNA more readily detected in induced sputum than in throat swabs of convalescent COVID-19 patients |pdf=|usr=}}
 
{{ttp|p=32300245|t=2020. CRISPR-Cas12-based detection of SARS-CoV-2 |pdf=|usr=}}
 
{{ttp|p=32300245|t=2020. CRISPR-Cas12-based detection of SARS-CoV-2 |pdf=|usr=}}
{{tp|p=32350462|t=2020. Antibody responses to SARS-CoV-2 in patients with COVID-19 |pdf=|usr=}}
+
 
 
{{tp|p=32273607|t=2020. Virological assessment of SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32273607|t=2020. Virological assessment of SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32235945|t=2020. Virological assessment of hospitalized patients with COVID-2019 |pdf=|usr=}}
 
{{tp|p=32235945|t=2020. Virological assessment of hospitalized patients with COVID-2019 |pdf=|usr=}}
{{tp|p=32313159|t=2020. Will antibody tests for the coronavirus really change everything?|pdf=|usr=}}
+
 
  
 
{{tp|p=32311181|t=2020. SARS-CoV-2: What can saliva tell us?|pdf=|usr=}}
 
{{tp|p=32311181|t=2020. SARS-CoV-2: What can saliva tell us?|pdf=|usr=}}
{{tp|p=32364358|t=2020.  A specifikus IgM- es IgG-antitesteket detektalo gyorstesztek erteke a SARS CoV-2 virusfertozes kimutatasaban (A COVID-19-pandemia orvosszakmai kerdesei) |pdf=|usr=}}
+
 
 
{{tp|p=32302058|t=2020. Laboratory testing of SARS?CoV, MERS?CoV, and SARS?CoV?2 (2019?nCoV): Current status, challenges, and countermeasures |pdf=|usr=}}
 
{{tp|p=32302058|t=2020. Laboratory testing of SARS?CoV, MERS?CoV, and SARS?CoV?2 (2019?nCoV): Current status, challenges, and countermeasures |pdf=|usr=}}
 
{{tp|p=32179122|t=2020. Viral loads of SARS-CoV, MERS-CoV and SARS-CoV-2 in respiratory specimens: What have we learned?|pdf=|usr=}}
 
{{tp|p=32179122|t=2020. Viral loads of SARS-CoV, MERS-CoV and SARS-CoV-2 in respiratory specimens: What have we learned?|pdf=|usr=}}
Zeile 254: Zeile 250:
 
{{tp|p=32382657|t=2020. Assay Techniques and Test Development for COVID-19 Diagnosis |pdf=|usr=}}
 
{{tp|p=32382657|t=2020. Assay Techniques and Test Development for COVID-19 Diagnosis |pdf=|usr=}}
 
{{tp|p=32387093|t=2020. Distinct changes in the real-time PCR detectability of certain SARS-CoV-2 target  sequences |pdf=|usr=}}
 
{{tp|p=32387093|t=2020. Distinct changes in the real-time PCR detectability of certain SARS-CoV-2 target  sequences |pdf=|usr=}}
{{tp|p=32382418|t=2020. Detection of IgM and IgG antibodies in patients with coronavirus disease 2019 |pdf=|usr=}}
+
 
 
{{ttp|p=32313543|t=2018. Host Cell Mimic Polymersomes for Rapid Detection of Highly Pathogenic Influenza Virus via a Viral Fusion and Cell Entry Mechanism |pdf=|usr=}}
 
{{ttp|p=32313543|t=2018. Host Cell Mimic Polymersomes for Rapid Detection of Highly Pathogenic Influenza Virus via a Viral Fusion and Cell Entry Mechanism |pdf=|usr=}}
 
{{tp|p=32322898|t=ä. Double-Edged Spike: Are SARS-CoV-2 Serologic Tests Safe Right Now?|pdf=|usr=}}
 
{{tp|p=32322898|t=ä. Double-Edged Spike: Are SARS-CoV-2 Serologic Tests Safe Right Now?|pdf=|usr=}}
Zeile 268: Zeile 264:
 
{{tp|p=32403008|t=2020. A RT-PCR assay for the detection of coronaviruses from four genera |pdf=|usr=}}
 
{{tp|p=32403008|t=2020. A RT-PCR assay for the detection of coronaviruses from four genera |pdf=|usr=}}
 
{{tp|p=32388472|t=2020. The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China |pdf=|usr=}}
 
{{tp|p=32388472|t=2020. The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China |pdf=|usr=}}
{{tp|p=32387968|t=2020. Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest  computed tomography for the diagnosis of COVID-19 |pdf=|usr=}}
+
 
 
{{tp|p=32416599|t=2020. Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG |pdf=|usr=}}
 
{{tp|p=32416599|t=2020. Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG |pdf=|usr=}}
 
{{tp|p=32388471|t=2020. Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for  rapid on-demand testing in the hospital setting |pdf=|usr=}}
 
{{tp|p=32388471|t=2020. Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for  rapid on-demand testing in the hospital setting |pdf=|usr=}}
Zeile 277: Zeile 273:
 
{{tp|p=32006218|t=ä. Clinical role of viral identification by a polymerase chain reaction-based diagnostic panel in adults hospitalized with community-acquired pneumonia |pdf=|usr=}}
 
{{tp|p=32006218|t=ä. Clinical role of viral identification by a polymerase chain reaction-based diagnostic panel in adults hospitalized with community-acquired pneumonia |pdf=|usr=}}
 
{{tp|p=C7194818|t=ä. Pooling of samples for testing for SARS-CoV-2 in asymptomatic people |pdf=|usr=}}
 
{{tp|p=C7194818|t=ä. Pooling of samples for testing for SARS-CoV-2 in asymptomatic people |pdf=|usr=}}
{{tp|p=32466975|t=ä. Rapid immunoglobulin test confirms a suspected case of COVID-19 |pdf=|usr=}}
+
 
 
{{tp|p=32248474|t=2020. Vergessen Sie die Schnellteste auf Coronavirus!|pdf=|usr=}}
 
{{tp|p=32248474|t=2020. Vergessen Sie die Schnellteste auf Coronavirus!|pdf=|usr=}}
 
{{tp|p=32342388|t=2020. Anwendung von Antikörper-Schnelltests ist Körperverletzung:  Dr  Matthias Orth |pdf=|usr=}}
 
{{tp|p=32342388|t=2020. Anwendung von Antikörper-Schnelltests ist Körperverletzung:  Dr  Matthias Orth |pdf=|usr=}}
Zeile 287: Zeile 283:
 
{{tp|p=32358955|t=ä. Still much to learn about the diagnostic role of SARS-CoV-2 antibody detection |pdf=|usr=}}
 
{{tp|p=32358955|t=ä. Still much to learn about the diagnostic role of SARS-CoV-2 antibody detection |pdf=|usr=}}
 
{{tp|p=32149770|t=2020. High-throughput sequencing for confirmation of suspected 2019-nCoV infection identified by fluorescence quantitative polymerase chain reaction |pdf=|usr=}}
 
{{tp|p=32149770|t=2020. High-throughput sequencing for confirmation of suspected 2019-nCoV infection identified by fluorescence quantitative polymerase chain reaction |pdf=|usr=}}
{{tp|p=32198501|t=ä. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19) |pdf=|usr=}}
+
 
 
{{tp|p=32396505|t=2020. US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2.|pdf=|usr=007}}
 
{{tp|p=32396505|t=2020. US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2.|pdf=|usr=007}}
  
Zeile 298: Zeile 294:
 
{{tp|p=32492531|t=2020. Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples.|pdf=|usr=007}}
 
{{tp|p=32492531|t=2020. Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples.|pdf=|usr=007}}
  
{{tp|p=32431052|t=2020. SARS-CoV-2 lgM/lgG antibody detection confirms the infection after three negative nucleic acid detection.|pdf=|usr=007}}
 
{{tp|p=32443459|t=2020. Point-of-Care Diagnostic Tests for Detecting SARS-CoV-2 Antibodies: A Systematic Review and Meta-Analysis of Real-World Data.|pdf=|usr=007}}
 
 
{{tp|p=32429101|t=2020. Use of Saliva for Diagnosis and Monitoring the SARS-CoV-2: A General Perspective.|pdf=|usr=007}}
 
{{tp|p=32429101|t=2020. Use of Saliva for Diagnosis and Monitoring the SARS-CoV-2: A General Perspective.|pdf=|usr=007}}
{{tp|p=32381641|t=2020. Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho.|pdf=|usr=007}}
+
 
 
{{tp|p=32404480|t=2020. Evaluation of a rapid diagnostic assay for detection of SARS CoV-2 antigen in nasopharyngeal swab.|pdf=|usr=007}}
 
{{tp|p=32404480|t=2020. Evaluation of a rapid diagnostic assay for detection of SARS CoV-2 antigen in nasopharyngeal swab.|pdf=|usr=007}}
 
{{tp|p=32393482|t=2020. Open Development and Clinical Validation Of Multiple 3D-Printed Nasopharyngeal Collection Swabs: Rapid Resolution of a Critical COVID-19 Testing Bottleneck.|pdf=|usr=007}}
 
{{tp|p=32393482|t=2020. Open Development and Clinical Validation Of Multiple 3D-Printed Nasopharyngeal Collection Swabs: Rapid Resolution of a Critical COVID-19 Testing Bottleneck.|pdf=|usr=007}}
Zeile 307: Zeile 301:
 
{{tp|p=32512376|t=2020. Evaluation of rapid diagnosis of novel coronavirus disease (COVID-19) using loop-mediated isothermal amplification.|pdf=|usr=007}}
 
{{tp|p=32512376|t=2020. Evaluation of rapid diagnosis of novel coronavirus disease (COVID-19) using loop-mediated isothermal amplification.|pdf=|usr=007}}
 
{{tp|p=32434706|t=2020. Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2.|pdf=|usr=007}}
 
{{tp|p=32434706|t=2020. Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2.|pdf=|usr=007}}
{{tp|p=32505777|t=2020. Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays.|pdf=|usr=007}}
 
{{tp|p=32458479|t=2020. Diagnostic performance of immunochromatography assay for rapid detection of IgM and IgG in coronavirus disease 2019.|pdf=|usr=007}}
 
 
{{tp|p=32342925|t=2020. Challenges of Covid-19 testing.|pdf=|usr=007}}
 
{{tp|p=32342925|t=2020. Challenges of Covid-19 testing.|pdf=|usr=007}}
 
{{tp|p=32491306|t=2020. The different tests for the diagnosis of COVID-19 - A review in Brazil so far.|pdf=|usr=007}}
 
{{tp|p=32491306|t=2020. The different tests for the diagnosis of COVID-19 - A review in Brazil so far.|pdf=|usr=007}}
Zeile 330: Zeile 322:
 
{{ttp|p=32302471|t=2020. How to Obtain a Nasopharyngeal Swab Specimen.|pdf=|usr=007}}
 
{{ttp|p=32302471|t=2020. How to Obtain a Nasopharyngeal Swab Specimen.|pdf=|usr=007}}
 
{{tp|p=32463086|t=2020. Clinical Utility of Buccal Swabs for Sars-Cov-2 Detection in Covid-19-Infected Children.|pdf=|usr=007}}
 
{{tp|p=32463086|t=2020. Clinical Utility of Buccal Swabs for Sars-Cov-2 Detection in Covid-19-Infected Children.|pdf=|usr=007}}
{{tp|p=32510168|t=2020. Clinical performance of different SARS-CoV-2 IgG antibody tests.|pdf=|usr=007}}
+
 
 
{{tp|p=32501535|t=2020. Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole genome sequencing.|pdf=|usr=007}}
 
{{tp|p=32501535|t=2020. Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole genome sequencing.|pdf=|usr=007}}
 
{{tp|p=32484950|t=2020. Amplification of human beta-glucuronidase gene for appraising the accuracy of negative SARS-CoV-2 RT-PCR results in upper respiratory tract specimens.|pdf=|usr=007}}
 
{{tp|p=32484950|t=2020. Amplification of human beta-glucuronidase gene for appraising the accuracy of negative SARS-CoV-2 RT-PCR results in upper respiratory tract specimens.|pdf=|usr=007}}
Zeile 336: Zeile 328:
 
{{tp|p=32504946|t=2020. Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performance.|pdf=|usr=007}}
 
{{tp|p=32504946|t=2020. Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performance.|pdf=|usr=007}}
 
{{tp|p=32401064|t=2020. CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia.|pdf=|usr=007}}
 
{{tp|p=32401064|t=2020. CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia.|pdf=|usr=007}}
{{tp|p=32504735|t=2020. Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients.|pdf=|usr=007}}
 
{{tp|p=32442248|t=2020. Testing for Novel Covid-19 antibodies: a necessary adjunct.|pdf=|usr=007}}
 
 
{{tp|p=32427340|t=2020. Influence of storage conditions on SARS-CoV-2 nucleic acid detection in throat swabs.|pdf=|usr=007}}
 
{{tp|p=32427340|t=2020. Influence of storage conditions on SARS-CoV-2 nucleic acid detection in throat swabs.|pdf=|usr=007}}
 
{{tp|p=32427334|t=2020. Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients.|pdf=|usr=007}}
 
{{tp|p=32427334|t=2020. Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients.|pdf=|usr=007}}
Zeile 350: Zeile 340:
 
{{tp|p=32386187|t=2020. Antibody tests for COVID-19: drawing attention to the importance of analytical specificity.|pdf=|usr=007}}
 
{{tp|p=32386187|t=2020. Antibody tests for COVID-19: drawing attention to the importance of analytical specificity.|pdf=|usr=007}}
 
{{tp|p=32459192|t=2020. Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence.|pdf=|usr=007}}
 
{{tp|p=32459192|t=2020. Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence.|pdf=|usr=007}}
{{tp|p=32459191|t=2020. Diagnostic performance of a SARS-CoV-2 IgG/IgM lateral flow immunochromatography assay in symptomatic patients presenting to the emergency department.|pdf=|usr=007}}
 
{{tp|p=32447328|t=2020. Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody.|pdf=|usr=007}}
 
{{tp|p=32472684|t=2020. Seroconversion rate and diagnostic accuracy of serological tests for COVID-19.|pdf=|usr=007}}
 
 
{{tp|p=32472672|t=2020. What is the role of SARS-CoV-2 PCR testing in discontinuation of transmission-based precautions for COVID-19 patients?|pdf=|usr=007}}
 
{{tp|p=32472672|t=2020. What is the role of SARS-CoV-2 PCR testing in discontinuation of transmission-based precautions for COVID-19 patients?|pdf=|usr=007}}
 
{{tp|p=32445559|t=2020. Whole nucleocapsid protein of SARS-CoV-2 may cause false positive results in serological assays.|pdf=|usr=007}}
 
{{tp|p=32445559|t=2020. Whole nucleocapsid protein of SARS-CoV-2 may cause false positive results in serological assays.|pdf=|usr=007}}
Zeile 359: Zeile 346:
 
{{tp|p=32320539|t=2020. La Asociacion Catalana de Salud Laboral (@SCSL) ante el gran reto de la COVID-19.|pdf=|usr=007}}
 
{{tp|p=32320539|t=2020. La Asociacion Catalana de Salud Laboral (@SCSL) ante el gran reto de la COVID-19.|pdf=|usr=007}}
 
{{tp|p=32510339|t=2020. Homogeneous circle-to-circle amplification for real-time optomagnetic detection of SARS-CoV-2 RdRp coding sequence.|pdf=|usr=007}}
 
{{tp|p=32510339|t=2020. Homogeneous circle-to-circle amplification for real-time optomagnetic detection of SARS-CoV-2 RdRp coding sequence.|pdf=|usr=007}}
{{tp|p=32439655|t=2020. Covid-19: Two antibody tests are "highly specific" but vary in sensitivity, evaluations find.|pdf=|usr=007}}
+
 
 
{{tp|p=32398230|t=2020. Interpreting a covid-19 test result.|pdf=|usr=007}}
 
{{tp|p=32398230|t=2020. Interpreting a covid-19 test result.|pdf=|usr=007}}
{{tp|p=32349966|t=2020. Covid-19: Antibody test that claims to be 99% accurate is certified by EU.|pdf=|usr=007}}
+
 
 
{{tp|p=32385433|t=2020. Saliva testing for COVID-19?|pdf=|usr=007}}
 
{{tp|p=32385433|t=2020. Saliva testing for COVID-19?|pdf=|usr=007}}
 
{{tp|p=32472673|t=2020. Cohort PCR Testing: A Strategic Method for Rapid SARS-CoV-2 Screening.|pdf=|usr=007}}
 
{{tp|p=32472673|t=2020. Cohort PCR Testing: A Strategic Method for Rapid SARS-CoV-2 Screening.|pdf=|usr=007}}
Zeile 373: Zeile 360:
 
{{tp|p=32482077|t=2020. Biosensors for Managing the COVID-19 Cytokine Storm: Challenges Ahead.|pdf=|usr=007}}
 
{{tp|p=32482077|t=2020. Biosensors for Managing the COVID-19 Cytokine Storm: Challenges Ahead.|pdf=|usr=007}}
 
{{tp|p=32455796|t=2020. Optimization of the CDC Protocol of Molecular Diagnosis of COVID-19 for Timely Diagnosis.|pdf=|usr=007}}
 
{{tp|p=32455796|t=2020. Optimization of the CDC Protocol of Molecular Diagnosis of COVID-19 for Timely Diagnosis.|pdf=|usr=007}}
{{tp|p=32438677|t=2020. Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-Analysis.|pdf=|usr=007}}
+
 
 
{{tp|p=32434807|t=2020. COVID-19 serologic testing: FAQs and caveats.|pdf=|usr=007}}
 
{{tp|p=32434807|t=2020. COVID-19 serologic testing: FAQs and caveats.|pdf=|usr=007}}
{{tp|p=32505774|t=2020. SARS-CoV-2 antibody characterization in emergency department, hospitalized and convalescent patients by two semi-quantitative immunoassays.|pdf=|usr=007}}
+
 
 
{{tp|p=32456766|t=2020. Are patients with systemic lupus erythematosus more prone to result false-positive for SARS-CoV2 serology?|pdf=|usr=007}}
 
{{tp|p=32456766|t=2020. Are patients with systemic lupus erythematosus more prone to result false-positive for SARS-CoV2 serology?|pdf=|usr=007}}
 
{{tp|p=32508026|t=2020. A new and rapid approach for detecting COVID-19 based on S1 protein fragments.|pdf=|usr=007}}
 
{{tp|p=32508026|t=2020. A new and rapid approach for detecting COVID-19 based on S1 protein fragments.|pdf=|usr=007}}
Zeile 383: Zeile 370:
 
{{tp|p=32407189|t=2020. Recommendation of fecal specimen for routine molecular detection of SARS-CoV-2 and for COVID-19 discharge criteria.|pdf=|usr=007}}
 
{{tp|p=32407189|t=2020. Recommendation of fecal specimen for routine molecular detection of SARS-CoV-2 and for COVID-19 discharge criteria.|pdf=|usr=007}}
 
{{tp|p=32294815|t=2020. [Clinical observation on increasing the positive rate of novel coronavirus nucleic acid tests by sputum excretion induced by nebulizer therapy].|pdf=|usr=007}}  
 
{{tp|p=32294815|t=2020. [Clinical observation on increasing the positive rate of novel coronavirus nucleic acid tests by sputum excretion induced by nebulizer therapy].|pdf=|usr=007}}  
{{tp|p=32398876|t=2020. A serological assay to detect SARS-CoV-2 seroconversion in humans.|pdf=|usr=007}}
+
 
 
{{tp|p=32385368|t=2020. First CRISPR test for the coronavirus approved in the United States.|pdf=|usr=007}}
 
{{tp|p=32385368|t=2020. First CRISPR test for the coronavirus approved in the United States.|pdf=|usr=007}}
 
{{tp|p=32407257|t=2020. Assessing the Value of Diagnostic Tests in the New World of COVID-19 Pandemic.|pdf=|usr=007}}
 
{{tp|p=32407257|t=2020. Assessing the Value of Diagnostic Tests in the New World of COVID-19 Pandemic.|pdf=|usr=007}}
Zeile 394: Zeile 381:
 
{{tp|p=32414781|t=2020. Serology assays to manage COVID-19.|pdf=|usr=007}}
 
{{tp|p=32414781|t=2020. Serology assays to manage COVID-19.|pdf=|usr=007}}
  
{{tp|p=32473021|t=2020. Performance of SARS-CoV-2 antibody assays in different stages of the infection: Comparison of commercial ELISA and rapid tests.|pdf=|usr=007}}
+
 
 
{{tp|p=32229604|t=2020. Evaluation of Saline, Phosphate-Buffered Saline, and Minimum Essential Medium as Potential Alternatives to Viral Transport Media for SARS-CoV-2 Testing.|pdf=|usr=007}}
 
{{tp|p=32229604|t=2020. Evaluation of Saline, Phosphate-Buffered Saline, and Minimum Essential Medium as Potential Alternatives to Viral Transport Media for SARS-CoV-2 Testing.|pdf=|usr=007}}
 
{{tp|p=32483586|t=2020. Clinical Validation of a SARS-CoV-2 Real-Time Reverse Transcription PCR Assay Targeting the Nucleocapsid Gene.|pdf=|usr=007}}
 
{{tp|p=32483586|t=2020. Clinical Validation of a SARS-CoV-2 Real-Time Reverse Transcription PCR Assay Targeting the Nucleocapsid Gene.|pdf=|usr=007}}
Zeile 403: Zeile 390:
 
{{tp|p=32435872|t=2020. Lab-on-a-Chip Devices for Point-of-Care Medical Diagnostics.|pdf=|usr=007}}
 
{{tp|p=32435872|t=2020. Lab-on-a-Chip Devices for Point-of-Care Medical Diagnostics.|pdf=|usr=007}}
  
{{tp|p=32461288|t=2020. Patients with Common Cold Coronaviruses Tested Negative for IgG Antibody to SARS-CoV-2.|pdf=|usr=007}}
+
 
 
{{tp|p=32461287|t=2020. Comparison of two commercial molecular tests and a laboratory-developed modification of the CDC 2019-nCoV RT-PCR assay for the detection of SARS-CoV-2.|pdf=|usr=007}}
 
{{tp|p=32461287|t=2020. Comparison of two commercial molecular tests and a laboratory-developed modification of the CDC 2019-nCoV RT-PCR assay for the detection of SARS-CoV-2.|pdf=|usr=007}}
 
{{tp|p=32461285|t=2020. Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens.|pdf=|usr=007}}
 
{{tp|p=32461285|t=2020. Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens.|pdf=|usr=007}}
Zeile 431: Zeile 418:
 
{{tp|p=32528710|t=2020. Persistence of positive severe acute respiratory syndrome coronavirus-2 reverse transcription-polymerase chain reaction test result for 24 days in a hospitalized asymptomatic carrier.|pdf=|usr=008}}
 
{{tp|p=32528710|t=2020. Persistence of positive severe acute respiratory syndrome coronavirus-2 reverse transcription-polymerase chain reaction test result for 24 days in a hospitalized asymptomatic carrier.|pdf=|usr=008}}
  
{{tp|p=32412044|t=2020. Antibody Testing for COVID-19.|pdf=|usr=008}}
+
 
 
{{tp|p=32487335|t=2020. Nasopharyngeal swab collection in the suspicion of Covid-19.|pdf=|usr=008}}
 
{{tp|p=32487335|t=2020. Nasopharyngeal swab collection in the suspicion of Covid-19.|pdf=|usr=008}}
 
{{tp|p=32427600|t=2020. Interpreting the COVID-19 Test Results: A Guide for Physiatrists.|pdf=|usr=008}}
 
{{tp|p=32427600|t=2020. Interpreting the COVID-19 Test Results: A Guide for Physiatrists.|pdf=|usr=008}}
{{tp|p=32355546|t=2020. Clinical evaluation of a rapid colloidal gold immunochromatography assay for SARS-Cov-2 IgM/IgG.|pdf=|usr=008}}
+
 
  
 
{{tp|p=32438806|t=2020. Novel One-Step Single-Tube Nested Quantitative Real-Time PCR Assay for Highly Sensitive Detection of SARS-CoV-2.|pdf=|usr=008}}
 
{{tp|p=32438806|t=2020. Novel One-Step Single-Tube Nested Quantitative Real-Time PCR Assay for Highly Sensitive Detection of SARS-CoV-2.|pdf=|usr=008}}
Zeile 456: Zeile 443:
 
{{tp|p=32402061|t=2020. Clinical Performance of Two SARS-CoV-2 Serologic Assays.|pdf=|usr=008}}
 
{{tp|p=32402061|t=2020. Clinical Performance of Two SARS-CoV-2 Serologic Assays.|pdf=|usr=008}}
 
{{tp|p=32485157|t=2020. Diagnostic performances and thresholds: The key to harmonization in serological SARS-CoV-2 assays?|pdf=|usr=008}}
 
{{tp|p=32485157|t=2020. Diagnostic performances and thresholds: The key to harmonization in serological SARS-CoV-2 assays?|pdf=|usr=008}}
{{tp|p=32485155|t=2020. Comparison of the Elecsys(R) Anti-SARS-CoV-2 immunoassay with the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma.|pdf=|usr=008}}
 
{{tp|p=32526218|t=2020. Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma.|pdf=|usr=008}}
 
  
  
  
{{tp|p=32473953|t=2020. Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients.|pdf=|usr=008}}
+
 
 
{{tp|p=32422410|t=2020. Multiple-centre clinical evaluation of an ultrafast single-tube assay for SARS-CoV-2 RNA.|pdf=|usr=008}}
 
{{tp|p=32422410|t=2020. Multiple-centre clinical evaluation of an ultrafast single-tube assay for SARS-CoV-2 RNA.|pdf=|usr=008}}
 
{{tp|p=32422408|t=2020. Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study.|pdf=|usr=008}}
 
{{tp|p=32422408|t=2020. Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study.|pdf=|usr=008}}
{{tp|p=32531475|t=2020. Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection.|pdf=|usr=008}}
+
 
 
{{tp|p=32502646|t=2020. Comparison of diagnostic accuracies of rapid serological tests and ELISA to molecular diagnostics in patients with suspected coronavirus disease 2019 presenting to the hospital.|pdf=|usr=008
 
{{tp|p=32502646|t=2020. Comparison of diagnostic accuracies of rapid serological tests and ELISA to molecular diagnostics in patients with suspected coronavirus disease 2019 presenting to the hospital.|pdf=|usr=008
 
{{tp|p=32520228|t=2020. Sensitivity of the Wondfo One Step COVID-19 test using serum samples.|pdf=|usr=008}}
 
{{tp|p=32520228|t=2020. Sensitivity of the Wondfo One Step COVID-19 test using serum samples.|pdf=|usr=008}}
Zeile 473: Zeile 458:
 
{{tp|p=32483515|t=2020. What Do We Need to Know to Improve Diagnostic Testing Methods for the 2019 Novel Coronavirus?|pdf=|usr=008}}
 
{{tp|p=32483515|t=2020. What Do We Need to Know to Improve Diagnostic Testing Methods for the 2019 Novel Coronavirus?|pdf=|usr=008}}
  
{{tp|p=32302069|t=2020. SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup.|pdf=|usr=008}}
+
 
 
{{tp|p=32386354|t=2020. Can dried blood spots (DBS) contribute to conducting comprehensive SARS-CoV-2 antibody tests?|pdf=|usr=008}}
 
{{tp|p=32386354|t=2020. Can dried blood spots (DBS) contribute to conducting comprehensive SARS-CoV-2 antibody tests?|pdf=|usr=008}}
  
Zeile 488: Zeile 473:
 
{{tp|p=32441935|t=2020. A Reverse-Transcription Recombinase-Aided Amplification Assay for Rapid Detection of the 2019 Novel Coronavirus (SARS-CoV-2).|pdf=|usr=008}}
 
{{tp|p=32441935|t=2020. A Reverse-Transcription Recombinase-Aided Amplification Assay for Rapid Detection of the 2019 Novel Coronavirus (SARS-CoV-2).|pdf=|usr=008}}
 
{{tp|p=32490854|t=2020. A novel liquid biopsy-based approach for highly specific cancer diagnostics: mitigating false responses in assaying patient plasma-derived circulating microRNAs through combined SERS and plasmon-enhanced fluorescence analyses.|pdf=|usr=008}}
 
{{tp|p=32490854|t=2020. A novel liquid biopsy-based approach for highly specific cancer diagnostics: mitigating false responses in assaying patient plasma-derived circulating microRNAs through combined SERS and plasmon-enhanced fluorescence analyses.|pdf=|usr=008}}
{{tp|p=32343598|t=2020. Serological tests for COVID-19 antibodies: Limitations must be recognized.|pdf=|usr=008}}
+
 
  
 
{{tp|p=32487681|t=2020. SARS-CoV-2 serology: Test, test, test, but interpret with caution!|pdf=|usr=008}}
 
{{tp|p=32487681|t=2020. SARS-CoV-2 serology: Test, test, test, but interpret with caution!|pdf=|usr=008}}
Zeile 507: Zeile 492:
 
{{tp|p=32489177|t=2020. Authors' response: SARS-CoV-2 detection by real-time RT-PCR.|pdf=|usr=008}}
 
{{tp|p=32489177|t=2020. Authors' response: SARS-CoV-2 detection by real-time RT-PCR.|pdf=|usr=008}}
 
{{tp|p=32489175|t=2020. Letter to the editor: SARS-CoV-2 detection by real-time RT-PCR.|pdf=|usr=008}}
 
{{tp|p=32489175|t=2020. Letter to the editor: SARS-CoV-2 detection by real-time RT-PCR.|pdf=|usr=008}}
{{tp|p=32400364|t=2020. Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples.|pdf=|usr=008}}
+
 
 
{{tp|p=32411619|t=2020. Current and Future Point-of-Care Tests for Emerging and New Respiratory Viruses and Future Perspectives.|pdf=|usr=008}}
 
{{tp|p=32411619|t=2020. Current and Future Point-of-Care Tests for Emerging and New Respiratory Viruses and Future Perspectives.|pdf=|usr=008}}
 
{{tp|p=32391022|t=2020. Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control.|pdf=|usr=008}}
 
{{tp|p=32391022|t=2020. Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control.|pdf=|usr=008}}
Zeile 531: Zeile 516:
  
  
{{tp|p=32479758|t=2020. SARS-CoV-2 Antibody Testing - Questions to be asked.|pdf=|usr=008}}
+
 
 
{{tp|p=32445839|t=2020. Clinical Testing For Covid-19.|pdf=|usr=008}}
 
{{tp|p=32445839|t=2020. Clinical Testing For Covid-19.|pdf=|usr=008}}
 
{{tp|p=32531884|t=2020. The Enemy Which Sealed the World: Effects of COVID-19 Diffusion on the Psychological State of the Italian Population.|pdf=|usr=008}}
 
{{tp|p=32531884|t=2020. The Enemy Which Sealed the World: Effects of COVID-19 Diffusion on the Psychological State of the Italian Population.|pdf=|usr=008}}
Zeile 543: Zeile 528:
 
{{tp|p=32516739|t=2020. Evaluation of the commercially available LightMix(R) Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection.|pdf=|usr=008}}
 
{{tp|p=32516739|t=2020. Evaluation of the commercially available LightMix(R) Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection.|pdf=|usr=008}}
 
{{tp|p=32504945|t=2020. Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study.|pdf=|usr=008}}
 
{{tp|p=32504945|t=2020. Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study.|pdf=|usr=008}}
{{tp|p=32485620|t=2020. Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies.|pdf=|usr=008}}
+
 
 
{{tp|p=32485618|t=2020. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis.|pdf=|usr=008}}
 
{{tp|p=32485618|t=2020. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis.|pdf=|usr=008}}
 
{{tp|p=32504943|t=2020. The utility of beta-2-microglobulin testing as a human cellular control in COVID-19 testing.|pdf=|usr=008}}
 
{{tp|p=32504943|t=2020. The utility of beta-2-microglobulin testing as a human cellular control in COVID-19 testing.|pdf=|usr=008}}

Version vom 26. Juni 2020, 07:29 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.





32282894 ä. Diagnostic Testing for Severe Acute Respiratory Syndrome?Related Coronavirus-2: A Narrative Review


32293168 ä. Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor
32223179 ä. Diagnosing COVID-19: The Disease and Tools for Detection
32281785 ä. Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection


32304208 ä. Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources
32227199 ä. SARS-CoV-2 Testing: Trials and Tribulations


Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea. PDF direct
32259132 2020. Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study
32331788 ä. Case-finding: Fast, Available, and Efficient Font-line Diagnostics for SARS-CoV-2
32290684 2020. Exhaled breath condensate as a potential specimen for diagnosing COVID-19
32364936 2020. Electrochemical biosensors for pathogen detection
32330437 ä. COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil


32360478 2020. Emerging key laboratory tests for patients with COVID-19
32077933 ä. ...Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak
32154877 ä. The SARS-CoV-2 Outbreak: Diagnosis, Infection Prevention, and Public Perception
32246822 ä. Potential false-negative nucleic acid testing results for Severe Acute Respiratory Syndrome Coronavirus 2 from thermal inactivation of samples with low viral loads
32353116 ä. Modeling SARS-CoV-2 positivity using laboratory data: timing is everything
32343775 ä. SARS-CoV-2 Serology: Much Hype, Little Data
32315390 ä. Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform
32282874 ä. Limits of Detection of Six Approved RT?PCR Kits for the Novel SARS-coronavirus-2 (SARS-CoV-2)
32031590 ä. Racing Towards the Development of Diagnostics for a Novel Coronavirus (2019-nCoV)
32229107 2020. Dynamic change process of target genes by RT-PCR testing of SARS-Cov-2 during the course of a Coronavirus Disease 2019 patient
32031583 ä. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia
32156607 ä. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020


32335089 ä. Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories
32315614 2020. Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients
32295319 2020. Innovative screening tests for COVID-19 in South Korea
32358960 ä. Evaluation of COVID-19 RT-qPCR test in multi-sample pools


32357206 ä. Role of serology in the COVID-19 pandemic
32221523 ä. Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients


32047895 ä. Consistent Detection of 2019 Novel Coronavirus in Saliva
32271374 ä. Effect of throat washings on detection of 2019 novel coronavirus


32241023 ä. Gargle lavage as a safe and sensitive alternative to swab samples to diagnose COVID-19: a case report in Japan


32306042 ä. Testing for SARS-CoV-2: Can We Stop at Two?
32276116 ä. Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay
32306036 ä. Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients


32326952 2020. SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression
32313785 ä. A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19
32295707 ä. Fast and simple high-throughput testing of COVID 19
32197339 2020. Point-of-Care RNA-Based Diagnostic Device for COVID-19
32260471 2020. In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends
32316113 2020. Combining Point-of-Care Diagnostics and Internet of Medical Things (IoMT) to Combat the COVID-19 Pandemic
32244841 2020. Blockchain and Artificial Intelligence Technology for Novel Coronavirus Disease-19 Self-Testing



32294051 2020. Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2
32273299 2020. Self-screening to reduce medical resource consumption facing the COVID-19 pandemic


32306864 2020. Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients
32196430 2020. Laboratory diagnosis of emerging human coronavirus infections - the state of the art
32207377 2020. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
32306853 2020. Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2
32286155 2020. Significance of serology testing to assist timely diagnosis of SARS-CoV-2 infections: implication from a family cluster
32174267 2020. Era of molecular diagnosis for pathogen identification of unexplained pneumonia, lessons to be learned
32102625 2020. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity
32065057 2020. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes
32020836 2020. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak


32270412 ä. Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2
32342252 ä. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards
32329811 2020. The nucleic acid test of induced sputum should be used for estimation of patients cure with 2019-nCov
32156329 2020. Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system
32209163 2020. Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020
32156330 2020. Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020
31992387 2020. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
32046815 2020. Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020
32347204 2020. Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020
32290902 2020. An alternative workflow for molecular detection of SARS-CoV-2 escape from the NA extraction kit-shortage, Copenhagen, Denmark, March 2020
32290904 2020. Roll-out of SARS-CoV-2 testing for healthcare workers at a large NHS Foundation Trust in the United Kingdom, March 2020
32156101 2020. Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19)
32297805 2020. Real-time RT-PCR in COVID-19 detection: issues affecting the results


32377507 ä. A Cautionary Tale of False-Negative Nasopharyngeal COVID-19 Testing
32242876 2020. Development of in vitro transcribed RNA as positive control for laboratory diagnosis of SARS-CoV-2 in India
32342674 2020. Glove-Wall System for Respiratory Specimen Collection and COVID-19 Mass Screening


32007627 2020. Novel coronavirus: From discovery to clinical diagnostics
32304994 ä. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients
32224986 2020. Human Saliva: Non-Invasive Fluid for Detecting Novel Coronavirus (2019-nCoV)


32371192 ä. Using the diagnostic model based on routine laboratory tests to distinguish patients infected with SARS-CoV-2 from those infected with influenza virus
32251798 2020. Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019
32344011 2020. Mild versus severe COVID-19: Laboratory markers
32315809 ä. Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously
32114193 2020. Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests
32370065 2020. Hybridization Chain Reactions Targeting the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
32344568 2020. RT-qPCR Testing of SARS-CoV-2: A Primer
32276333 2020. Development of a Novel, Genome Subtraction-Derived, SARS-CoV-2-Specific COVID-19-nsp2 Real-Time RT-PCR Assay and Its Evaluation Using Clinical Specimens
32325642 2020. A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2


32300101 2020. Saliva: potential diagnostic value and transmission of 2019-nCoV
32286019 2020. Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives
32269100 2020. Comparative Performance of SARS-CoV-2 Detection Assays using Seven Different Primer/Probe Sets and One Assay Kit
32350048 2020. Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories


32341143 2020. Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens
32341142 2020. Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection
32341141 2020. Evaluation of Transport Media and Specimen Transport Conditions for the Detection of SARS-CoV-2 Using Real Time Reverse Transcription PCR
32332061 2020. Clinical Evaluation of Three Sample-To-Answer Platforms for the Detection of SARS-CoV-2
32327448 2020. Comparison of Abbott ID Now and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients
32132196 2020. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens
32102856 2020. Negative Nasopharyngeal and Oropharyngeal Swabs Do Not Rule Out COVID-19
32317257 2020. Saliva as a non-invasive specimen for detection of SARS-CoV-2
32317256 2020. Validation of the Hologic s Aptima Unisex and Multitest Specimen collection kits used for Endocervical and Male Urethral Swab Specimen (Aptima Swab) for sample collection of SARS-CoV-2
32303565 2020. The Detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
32303564 2020. Comparison of Abbott ID Now, Diasorin Simplexa, and CDC FDA EUA methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19
32295896 2020. Nasal swab sampling for SARS-CoV-2: A convenient alternative in time of nasopharyngeal swab shortage


32277022 2020. Clinical evaluation of the cobas SARS-CoV-2 test and a diagnostic platform switch during 48 hours in the midst of the COVID-19 pandemic
32361322 2020. Interpret with caution: An evaluation of the commercial AusDiagnostics versus in-house developed assays for the detection of SARS-CoV-2 virus
32361324 ä. Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: a descriptive study
32302956 2020. Consistency analysis of COVID-19 nucleic acid tests and the changes of lung CT
32328218 ä. Salivary diagnostics in COVID-19: Future research implications



32360885 ä. Value and Challenges: Nucleic Acid Amplification Tests for SARS?CoV-2 in Hospitalized COVID-19 Patients
32298676 ä. Saliva is a reliable tool to detect SARS-CoV-2


32031264 2020. Evolving status of the 2019 novel coronavirus infection: Proposal of conventional serologic assays for disease diagnosis and infection monitoring

31944312 2020. Recent advances in the detection of respiratory virus infection in humans


32276051 ä. Development of Reverse Transcription Loop-Mediated Isothermal Amplification Assays Targeting SARS-CoV-2
32292623 2020. Recent advances and perspectives of nucleic acid detection for coronavirus
32159775 2020. Detection of SARS-CoV-2 in Different Types of Clinical Specimens
32250394 2020. Sample Pooling as a Strategy to Detect Community Transmission of SARS-CoV-2
32352933 2020. Characteristics and diagnosis rate of 5630 subjects receiving SARS-CoV-2 nucleic acid tests from Wuhan, China


32074516 2020. Development of Genetic Diagnostic Methods for Novel Coronavirus 2019 (nCoV-2019) in Japan
32350226 2020. An assessment of real-time RT-PCR kits for SARS-CoV-2 detection
32266524 ä. A case report of COVID-19 with false negative RT-PCR test: necessity of chest CT
32207257 2020. A Patient with COVID-19 Presenting a False-Negative Reverse Transcriptase Polymerase Chain Reaction Result
32341519 ä. Retrospective analysis of laboratory testing in 54 patients with severe- or critical-type 2019 novel coronavirus pneumonia
32322891 ä. Double-Edged Spike?Are SARS-CoV-2 Serologic Tests Safe Right Now?


32224308 ä. Understanding COVID-19: what does viral RNA load really mean?
32342928 2020. Upper respiratory tract sampling in COVID-19
32342927 2020. Diagnostic performance of COVID-19 serology assays
32217609 2020. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS?CoV-2/COVID-19
32361529 ä. Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19


32333644 2020. RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2
32183357 2020. 2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics
32106462 2020. Disposable DNA Amplification Chips with Integrated Low-Cost Heaters ?
32074444 2020. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients


C7187661 ä. Group Testing for SARS-CoV-2: Forward to the Past?

32358057 2020. Overcoming the bottleneck to widespread testing: A rapid review of nucleic acid testing approaches for COVID-19 detection
32373393 ä. Rapid and Sensitive Detection of COVID-19 Using CRISPR/Cas12a-based Detection with Naked Eye Readout, CRISPR/Cas12a-NER


32270436 ä. Detection of serum IgM and IgG for COVID-19 diagnosis
32327566 2020. One ventilator for two patients: feasibility and considerations of a last resort solution in case of equipment shortage
32378843 2020. Akutt lungesviktsyndrom hos covid-19-pasient med negative nasofarynksprover
32311437 ä. Detection and analysis of nucleic acid in various biological samples of COVID-19 patients
32283215 ä. False negative rate of COVID-19 is eliminated by using nasal swab test
32239445 ä. Development of a Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2


32293905 2020. SARS-CoV-2 Viral Load in Clinical Samples from Critically Ill Patients
32338536 2020. A Bayesian analysis of strategies to rule out COVID19 using reverse transcriptase-polymerase chain reaction (RT-PCR)
32294808 2020. The Royal College of Pathologists of Australasia (RCPA) position statement on COVID-19 (serology)
32367615 2020. Trends and Innovations in Biosensors for COVID-19 Mass Testing

32187837 2020. Supersensitive Multifluorophore RNA-FISH for Early Virus Detection and Flow-FISH by Using Click Chemistry
32221132 2020. In Silico assessment of the impact of 2019 novel coronavirus (2019-nCoV) genomic variation on published real-time quantitative polymerase chain reaction detection assays


32149771 2020. A case of 2019 novel coronavirus infected pneumonia with twice negative 2019-nCoV nucleic acid testing within 8 days


32191623 2020. The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks
32172228 2020. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)
32242831 2020. Clinical laboratory and SARS-CoV-2 infection: where do we stand?
32242829 2020. One disease, different features: COVID-19 laboratory and radiological findings in three Italian patients



32301748 2020. Clinical chemistry tests for patients with COVID-19 - important caveats for interpretation
32301745 2020. Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52 cases of novel coronavirus (SARS-Cov-2)-infected pneumonia (COVID-19)
32286242 2020. The value of urine biochemical parameters in the prediction of the severity of coronavirus disease 2019

32378969 2020. Spectroscopy as a tool for detection and monitoring of Coronavirus (COVID-19)
32357381 2020. Respiratory sampling for severe acute respiratory syndrome coronavirus 2: An Overview


32329102 2020. Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment
32295895 2020. Comparison of Copan ESwab and FLOQSwab for COVID-19 Diagnosis: Working around a Supply Shortage
32380382 ä. Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays

32357377 2020. Performing the nasopharyngeal and oropharyngeal swab for 2019-novel coronavirus (SARS-CoV-2) safely: How to dress, undress, and technical notes
32352180 2020. COVID-19: Nasal and oropharyngeal swab


32329138 2020. Who should perform the rhinopharyngeal swab in COVID-19 positive patients?
32356761 2020. Navigating the Pandemic Response Life Cycle: Molecular Diagnostics and Immunoassays in the Context of COVID-19 Management

32311826 2020. COVID-19 and the clinical hematology laboratory
32245835 2020. Laboratory Diagnosis of COVID-19: Current Issues and Challenges


32349033 2020. Novel biosensor platforms for the detection of coronavirus infection and SARS-CoV-2
32366669 2020. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test



32222993 ä. Genomic characterization and phylogenetic analysis of SARS?COV?2 in Italy


32096564 ä. Combination of RT?qPCR testing and clinical features for diagnosis of COVID?19 facilitates management of SARS?CoV?2 outbreak


32270882 2020. False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence {{tp|p=32347966|t=2020. An Evolving Approach to the Laboratory Assessment of COVID-19 |pdf=|usr
32311142 2020. Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China

32297981 2020. COVID-19: Recommended sampling sites at different stage of the disease


32271278 2020. Integrated Radiologic Algorithm for COVID-19 Pandemic

32374370 2020. Interpreting Diagnostic Tests for SARS-CoV-2


32367861 2020. Bronchoalveolar specimen can help detect COVID-19 in suspicious case with negative PCR for nasopharyngeal specimen test


32236503 2020. Testing Individuals for Coronavirus Disease 2019 (COVID-19)
32334422 2020. Smartphone-based multiplex 30-minute nucleic acid test of live virus from nasal swab extract


32171389 2020. SARS-CoV-2 RNA more readily detected in induced sputum than in throat swabs of convalescent COVID-19 patients

32300245 2020. CRISPR-Cas12-based detection of SARS-CoV-2


32273607 2020. Virological assessment of SARS-CoV-2
32235945 2020. Virological assessment of hospitalized patients with COVID-2019



32311181 2020. SARS-CoV-2: What can saliva tell us?


32302058 2020. Laboratory testing of SARS?CoV, MERS?CoV, and SARS?CoV?2 (2019?nCoV): Current status, challenges, and countermeasures
32179122 2020. Viral loads of SARS-CoV, MERS-CoV and SARS-CoV-2 in respiratory specimens: What have we learned?
32380210 ä. The Impacts of Viral Inactivating Methods On Quantitative RT-PCR for COVID-19
32302278 2020. The Appropriate Use of Testing for COVID-19
32223871 2020. Preliminary Results of Initial Testing for Coronavirus (COVID-19) in the Emergency Department


C7200353 2020. A nanoparticle pseudo pathogen for rapid detection and diagnosis of virus infection
C7169335 2020. Promising methods for detection of novel coronavirus SARS?CoV?2
C7144506 2020. Technical guidance for laboratory testing of 2019-nCoV infection (Third Edition)
32382657 2020. Assay Techniques and Test Development for COVID-19 Diagnosis
32387093 2020. Distinct changes in the real-time PCR detectability of certain SARS-CoV-2 target sequences

32313543 2018. Host Cell Mimic Polymersomes for Rapid Detection of Highly Pathogenic Influenza Virus via a Viral Fusion and Cell Entry Mechanism


32322898 ä. Double-Edged Spike: Are SARS-CoV-2 Serologic Tests Safe Right Now?

22174638 2011. Applications of Next-Generation Sequencing Technologies to Diagnostic Virology


32378133 ä. Initial Observations with Molecular Testing for COVID-19 in a Private Hospital in Mumbai, India
C7184367 ä. COVID-19 in Pediatrics: A Laboratory Perspective
32389405 ä. Understanding Antibody Testing for COVID-19
32416598 2020. SARS-CoV-2 detection by direct rRT-PCR without RNA extraction
32403010 2020. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies
32388470 2020. Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa? COVID-19 direct assay
32403007 2020. Self-collection: An appropriate alternative during the SARS-CoV-2 pandemic
32403009 2020. Five-minute point-of-care testing for SARS-CoV-2: Not there yet
32403008 2020. A RT-PCR assay for the detection of coronaviruses from four genera
32388472 2020. The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China


32416599 2020. Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG
32388471 2020. Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital setting
32380382 2020. Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays
32388468 2020. Multi-Stage Group Testing Improves Efficiency of Large-Scale COVID-19 Screening
32389784 ä. Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays


32006218 ä. Clinical role of viral identification by a polymerase chain reaction-based diagnostic panel in adults hospitalized with community-acquired pneumonia
C7194818 ä. Pooling of samples for testing for SARS-CoV-2 in asymptomatic people


32248474 2020. Vergessen Sie die Schnellteste auf Coronavirus!
32342388 2020. Anwendung von Antikörper-Schnelltests ist Körperverletzung: Dr Matthias Orth
32372836 2020. The problems with so-called immunity tests
32376476 ä. Limited effectiveness of systematic screening by nasopharyngeal RT-PCR of medicalized nursing home staff after a first case of COVID-19 in a resident
C7197557 ä. Selecting a SARS-CoV-2/COVID molecular testing method for your laboratory
32380210 2020. The impacts of viral inactivating methods on quantitative RT-PCR for COVID-19
32330305 2020. SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens
32358955 ä. Still much to learn about the diagnostic role of SARS-CoV-2 antibody detection
32149770 2020. High-throughput sequencing for confirmation of suspected 2019-nCoV infection identified by fluorescence quantitative polymerase chain reaction


32396505 2020. US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2.


32459137 2020. Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2.
32448084 2020. Analytical comparisons of SARS-COV-2 detection by qRT-PCR and ddPCR with multiple primer/probe sets.
32438868 2020. ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens.
32419639 2020. Viral loads in throat and anal swabs in children infected with SARS-CoV-2.
32492721 2020. COVID-19 Pandemic and Role of Human Saliva as a Testing Biofluid in Point-of-Care Technology.
32505692 2020. Molecular analysis of several in-house rRT-PCR protocols for SARS-CoV-2 detection in the context of genetic variability of the virus in Colombia.
32492531 2020. Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples.


32429101 2020. Use of Saliva for Diagnosis and Monitoring the SARS-CoV-2: A General Perspective.


32404480 2020. Evaluation of a rapid diagnostic assay for detection of SARS CoV-2 antigen in nasopharyngeal swab.
32393482 2020. Open Development and Clinical Validation Of Multiple 3D-Printed Nasopharyngeal Collection Swabs: Rapid Resolution of a Critical COVID-19 Testing Bottleneck.
32505778 2020. Persistent detection of SARS-CoV-2 RNA in patients and healthcare workers with COVID-19.
32512376 2020. Evaluation of rapid diagnosis of novel coronavirus disease (COVID-19) using loop-mediated isothermal amplification.
32434706 2020. Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2.
32342925 2020. Challenges of Covid-19 testing.
32491306 2020. The different tests for the diagnosis of COVID-19 - A review in Brazil so far.
32486477 2020. Development of a Portable, Ultra-Rapid and Ultra-Sensitive Cell-Based Biosensor for the Direct Detection of the SARS-CoV-2 S1 Spike Protein Antigen.
32459081 2020. Evaluacion de diferentes genes en la deteccion por RT-PCR del SARS-CoV-2 en muestras respiratorias y su evolucion en la infeccion.
32492294 2020. Swabs Collected by Patients or Health Care Workers for SARS-CoV-2 Testing.
32466536 2020. Graphene-Based Strategies in Liquid Biopsy and in Viral Diseases Diagnosis.
32395793 2020. SARS-CoV-2 infection virological diagnosis.


32400235 2020. The role of lower respiratory tract samples in the diagnosis of COVID-19.
32329388 2020. Positive RT-PCR test results after consecutively negative results in patients with COVID-19.
32384820 2020. Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays.
32466458 2020. Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2.
32492760 2020. Diagnostic Performance of a Rapid Point of Care Test for SARS-CoV-2 in an Urban ED Setting.
32474555 2020. Evaluation of RdRp & ORF-1b-nsp14-based real-time RT-PCR assays for confirmation of SARS-CoV-2 infection: An observational study.
32456750 2020. Hospital infection and COVID-19: Do not put all your eggs on the "swab" tests.
32423519 2020. Screening for COVID-19: Patient Factors Predicting Positive PCR Test.
32321609 2020. Diagnostic Options for Coronavirus Disease 2019 (COVID-19).
32449639 2020. SARS-CoV-2 RT-PCR: at least 2 viral targets are needed.
32420777 2020. Positive RT-PCR in urine from an asymptomatic patient with novel coronavirus 2019 infection: a case report.

32302471 2020. How to Obtain a Nasopharyngeal Swab Specimen.


32463086 2020. Clinical Utility of Buccal Swabs for Sars-Cov-2 Detection in Covid-19-Infected Children.


32501535 2020. Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole genome sequencing.
32484950 2020. Amplification of human beta-glucuronidase gene for appraising the accuracy of negative SARS-CoV-2 RT-PCR results in upper respiratory tract specimens.
32484942 2020. Potential pitfalls of routine SARS-CoV-2 serology for mass screening.
32504946 2020. Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performance.
32401064 2020. CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia.
32427340 2020. Influence of storage conditions on SARS-CoV-2 nucleic acid detection in throat swabs.
32427334 2020. Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients.
32397487 2020. Saliva-Friend and Foe in the COVID-19 Outbreak.
32475012 2020. Testing for SARS-CoV-2: the day the world turned its attention to the clinical laboratory.
32511679 2020. The Laboratory Diagnosis of COVID-19-- Frequently-Asked Questions.
32506118 2020. Occurrence and Timing of Subsequent SARS-CoV-2 RT-PCR Positivity Among Initially Negative Patients.
32504529 2020. Can the SARS-CoV-2 PCR Cycle Threshold Value and Time from Symptom Onset to Testing Predict Infectivity?
32437513 2020. Molecular and serological assays for SARS-CoV-2: insights from genome and clinical characteristics.
32484887 2020. Clinical performance of the Elecsys electrochemiluminescent immunoassay for the detection of SARS-CoV-2 total antibodies.
32484860 2020. Clinical Performance of the Roche SARS-CoV-2 Serologic Assay.
32386187 2020. Antibody tests for COVID-19: drawing attention to the importance of analytical specificity.
32459192 2020. Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence.
32472672 2020. What is the role of SARS-CoV-2 PCR testing in discontinuation of transmission-based precautions for COVID-19 patients?
32445559 2020. Whole nucleocapsid protein of SARS-CoV-2 may cause false positive results in serological assays.
32442256 2020. Predicting infectious SARS-CoV-2 from diagnostic samples.
32435816 2020. To Interpret the SARS-CoV-2 Test, Consider the Cycle Threshold Value.
32320539 2020. La Asociacion Catalana de Salud Laboral (@SCSL) ante el gran reto de la COVID-19.
32510339 2020. Homogeneous circle-to-circle amplification for real-time optomagnetic detection of SARS-CoV-2 RdRp coding sequence.


32398230 2020. Interpreting a covid-19 test result.


32385433 2020. Saliva testing for COVID-19?
32472673 2020. Cohort PCR Testing: A Strategic Method for Rapid SARS-CoV-2 Screening.
32462195 2020. Clinical Evaluation and Utilization of Multiple Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2.
32401598 2020. COVID-19 Real-time RTPCR: Does Positivity on Follow up RTPCR Always Imply Infectivity?
32401535 2020. Reply to: COVID-19 Real-time RTPCR: Does Positivity on Follow up RTPCR Always Imply Infectivity?
32420937 2020. Current laboratory diagnostics of coronavirus disease 2019 (COVID-19).
32420926 2020. Point-of-Care diagnostic of SARS-CoV-2: knowledge, attitudes, and perceptions (KAP) of medical workforce in Italy.
32506693 2020. Diagnosis of COVID-19 infection in children: less nasopharyngeal swabs, more saliva.
32501019 2020. 'Self-collected upper respiratory tract swabs for COVID-19 test': A feasible way to increase overall testing rate and conserve resources in South Africa.
32482077 2020. Biosensors for Managing the COVID-19 Cytokine Storm: Challenges Ahead.
32455796 2020. Optimization of the CDC Protocol of Molecular Diagnosis of COVID-19 for Timely Diagnosis.


32434807 2020. COVID-19 serologic testing: FAQs and caveats.


32456766 2020. Are patients with systemic lupus erythematosus more prone to result false-positive for SARS-CoV2 serology?
32508026 2020. A new and rapid approach for detecting COVID-19 based on S1 protein fragments.
32501021 2020. Community-based screening and testing for Coronavirus in Cape Town, South Africa: Short report.
32510340 2020. Diagnostic methods and potential portable biosensors for coronavirus disease 2019.

32450754 2020. Inappropriate Nasopharyngeal Sampling for SARS-CoV-2 Detection Is a Relevant Cause of False-Negative Reports.


32407189 2020. Recommendation of fecal specimen for routine molecular detection of SARS-CoV-2 and for COVID-19 discharge criteria.
32294815 2020. [Clinical observation on increasing the positive rate of novel coronavirus nucleic acid tests by sputum excretion induced by nebulizer therapy].


32385368 2020. First CRISPR test for the coronavirus approved in the United States.
32407257 2020. Assessing the Value of Diagnostic Tests in the New World of COVID-19 Pandemic.
32493981 2020. The COVID-19 testing debacle.
32358105 2020. Sniffing out Covid-19.
32270938 2020. Performance du frottis nasopharynge-PCR pour le diagnostic du Covid-19 - Recommandations pratiques sur la base des premieres donnees scientifiques.
32430309 2020. Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.
32493791 2020. COVID-19 diagnostics in context.
32439785 2020. COVID-19 spotlights medical diagnostics.
32414781 2020. Serology assays to manage COVID-19.



32229604 2020. Evaluation of Saline, Phosphate-Buffered Saline, and Minimum Essential Medium as Potential Alternatives to Viral Transport Media for SARS-CoV-2 Testing.
32483586 2020. Clinical Validation of a SARS-CoV-2 Real-Time Reverse Transcription PCR Assay Targeting the Nucleocapsid Gene.


32404473 2020. Towards effective diagnostic assays for COVID-19: a review.


32198190 2020. Practical laboratory considerations amidst the COVID-19 outbreak: early experience from Singapore.
32435872 2020. Lab-on-a-Chip Devices for Point-of-Care Medical Diagnostics.



32461287 2020. Comparison of two commercial molecular tests and a laboratory-developed modification of the CDC 2019-nCoV RT-PCR assay for the detection of SARS-CoV-2.
32461285 2020. Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens.
32444354 2020. Test Agreement Between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges.
32414839 2020. Stability of SARS-CoV-2 in PBS for Molecular Detection.
32414838 2020. Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2.
32404481 2020. Large-scale, in-house production of viral transport media to support SARS-CoV-2 PCR testing in a multi-hospital healthcare network during the COVID-19 pandemic.
32503847 2020. Multi-Center Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Assay for the Detection of SARS-CoV-2 in Oropharyngeal Swab Specimens.
32482633 2020. Clinical performance of the Luminex NxTAG CoV Extended Panel for SARS-CoV-2 detection in nasopharyngeal specimens of COVID-19 patients in Hong Kong.
32381643 2020. Comparison of Two High-Throughput Reverse Transcription-Polymerase Chain Reaction Systems for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2.
32381642 2020. Understanding, verifying and implementing Emergency Use Authorization molecular diagnostics for the detection of SARS-CoV-2 RNA.
32471894 2020. Performance of Abbott ID NOW COVID-19 rapid nucleic acid amplification test in nasopharyngeal swabs transported in viral media and dry nasal swabs, in a New York City academic institution.
32467359 2020. Influence of Different Inactivation Methods on Severe Acute Respiratory Syndrome Coronavirus 2 RNA Copy Number.

32502333 2020. Practical Guidelines for Collection, Manipulation and Inactivation of SARS-CoV-2 and COVID-19 Clinical Specimens.


32475066 2020. Two Detailed Plaque Assay Protocols for the Quantification of Infectious SARS-CoV-2.
32361691 2020. Molecular diagnostics at the times of SARS-CoV-2 outbreak. {{tp|p=32462501|t=2020. The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis?|pdf=|usr=0
32500987 2020. Characteristics and assessment of the usefulness of serological tests in the diagnostic of infections caused by coronavirus SARS-CoV-2 on the basis of available manufacturer's data and literature review.
32467977 2020. Challenges of community point-of-care antibody testing for COVID-19 herd-immunity in Japan.

008


32437124 2020. Selective Naked-Eye Detection of SARS-CoV-2 Mediated by N Gene Targeted Antisense Oligonucleotide Capped Plasmonic Nanoparticles.
32469511 2020. Virus Detection: What Were We Doing before COVID-19 Changed the World?


32528710 2020. Persistence of positive severe acute respiratory syndrome coronavirus-2 reverse transcription-polymerase chain reaction test result for 24 days in a hospitalized asymptomatic carrier.



32487335 2020. Nasopharyngeal swab collection in the suspicion of Covid-19.
32427600 2020. Interpreting the COVID-19 Test Results: A Guide for Physiatrists.



32438806 2020. Novel One-Step Single-Tube Nested Quantitative Real-Time PCR Assay for Highly Sensitive Detection of SARS-CoV-2.
32427657 2020. Can pediatric COVID-19 testing sensitivity be improved with sequential tests?
32496919 2020. Serodiagnostics for Severe Acute Respiratory Syndrome-Related Coronavirus-2: A Narrative Review.



32331789 2020. Global Threat of SARS-CoV-2/COVID-19 and the Need for More and Better Diagnostic Tools.


32453605 2020. Rapid and robust bioanalytical assays are critical for SARS-CoV-2 therapeutic and vaccine development and beyond.
32395391 2020. Development of a rapid test kit for SARS-CoV-2: an example of product design.
32419272 2020. Molecular Targets for the Testing of COVID-19.
32406424 2020. Covid-19: Why test? Who to test? How to test?
32533461 2020. Positive tracheal SARS-CoV-2 RNA test after three negative SARS-CoV-2 RNA tests in a patient with COVID-19.
32387502 2020. Reduced Physical Activity During COVID-19 Pandemic in Children With Congenital Heart Disease.


32427226 2020. An automated Residual Exemplar Local Binary Pattern and iterative ReliefF based corona detection method using lung X-ray image.
32534909 2020. First detection of SARS-CoV-2 by real-time reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay in pleural fluid.
32518132 2020. Operationalizing COVID-19 testing: Who, what, when, where, why, and how.
32384153 2020. Rapid detection of SARS-CoV-2 by low volume real-time single tube reverse transcription recombinase polymerase amplification using an exo probe with an internally linked quencher (exo-IQ).
32402061 2020. Clinical Performance of Two SARS-CoV-2 Serologic Assays.
32485157 2020. Diagnostic performances and thresholds: The key to harmonization in serological SARS-CoV-2 assays?




32422410 2020. Multiple-centre clinical evaluation of an ultrafast single-tube assay for SARS-CoV-2 RNA.
32422408 2020. Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study.

{{tp|p=32502646|t=2020. Comparison of diagnostic accuracies of rapid serological tests and ELISA to molecular diagnostics in patients with suspected coronavirus disease 2019 presenting to the hospital.|pdf=|usr=008
32520228 2020. Sensitivity of the Wondfo One Step COVID-19 test using serum samples.
32444479 2020. Incidental COVID-19 on PET/CT imaging.
32493742 2020. Diagnostic testing for SARS-CoV-2.



32483515 2020. What Do We Need to Know to Improve Diagnostic Testing Methods for the 2019 Novel Coronavirus?



32386354 2020. Can dried blood spots (DBS) contribute to conducting comprehensive SARS-CoV-2 antibody tests?



32383097 2020. Nasopharyngeal swabs during SARS-CoV-2 pandemic: a role for the otolaryngologist.



32530490 2020. A Simple Method for Detection of a Novel Coronavirus (SARS-CoV-2) using One-step RT-PCR followed by Restriction Fragment Length Polymorphism.

32535768 2020. COVID-19: molecular diagnostics overview.



32441935 2020. A Reverse-Transcription Recombinase-Aided Amplification Assay for Rapid Detection of the 2019 Novel Coronavirus (SARS-CoV-2).
32490854 2020. A novel liquid biopsy-based approach for highly specific cancer diagnostics: mitigating false responses in assaying patient plasma-derived circulating microRNAs through combined SERS and plasmon-enhanced fluorescence analyses.



32487681 2020. SARS-CoV-2 serology: Test, test, test, but interpret with caution!
32515793 2020. Why, when, and how to use lung ultrasound during the COVID-19 pandemic: enthusiasm and caution.
32527161 2020. How Fear Appeal Approaches in COVID-19 Health Communication May Be Harming the Global Community.
32533803 2020. The Covid-19 'infodemic': a new front for information professionals.
32522311 2020. RT-PCR tests for SARS-CoV-2 processed at a large Italian Hospital and false-negative results among confirmed COVID-19 cases.



32530790 2020. Ellen Grass Lecture: Wellness for Allied Healthcare Professionals in the Age of COVID-19.





32489177 2020. Authors' response: SARS-CoV-2 detection by real-time RT-PCR.
32489175 2020. Letter to the editor: SARS-CoV-2 detection by real-time RT-PCR.


32411619 2020. Current and Future Point-of-Care Tests for Emerging and New Respiratory Viruses and Future Perspectives.
32391022 2020. Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control.


32452225 2020. Nasopharyngeal swab or clinical-radiological evidence: the dark side of the moon for cancer patients in the COVID-19 era.
32432217 2020. COVID-19 Special Column: Principles Behind the Technology for Detecting SARS-CoV-2, the Cause of COVID-19.



32389155 2020. Utility of retesting for diagnosis of SARS-CoV-2/COVID-19 in hospitalized patients: Impact of the interval between tests.
32389132 2020. Pharynx gargle samples are suitable for SARS-CoV-2 diagnostic use and save personal protective equipment and swabs.


32532934 2020. COVID 19 diagnostic multiplicity and its role in community surveillance and control.


32344452 2020. Rapid detection of SARS-CoV-2 in saliva: can an endodontist take the lead in point-of-care COVID-19 testing?


32417248 2020. SARS-CoV-2 infection diagnosed only by cell culture isolation before the local outbreak in an Italian seven-week-old suckling baby.
32518072 2020. Culture-based virus isolation to evaluate potential infectivity of clinical specimens tested for COVID-19.
32522596 2020. Recent Advances in Molecular diagnosis curbing the COVID-19.
32535302 2020. Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak.
32497809 2020. Evaluation of novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples.




32445839 2020. Clinical Testing For Covid-19.
32531884 2020. The Enemy Which Sealed the World: Effects of COVID-19 Diffusion on the Psychological State of the Italian Population.
32098019 2020. Communicating the Risk of Death from Novel Coronavirus Disease (COVID-19).


32281158 2020. The pandemic paradox: The consequences of COVID-19 on domestic violence.
32344460 2020. The potential for COVID-19 to contribute to compassion fatigue in critical care nurses.
32320509 2020. Covid-19: Supporting nurses' psychological and mental health.
32535398 2020. Comparison of a laboratory-developed test targeting the envelope gene with three nucleic acid amplification tests for detection of SARS-CoV-2.
32504944 2020. Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: Experiences of a general hospital.
32516739 2020. Evaluation of the commercially available LightMix(R) Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection.
32504945 2020. Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study.


32485618 2020. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis.
32504943 2020. The utility of beta-2-microglobulin testing as a human cellular control in COVID-19 testing.
32425660 2020. A combined oropharyngeal/nares swab is a suitable alternative to nasopharyngeal swabs for the detection of SARS-CoV-2.
32535397 2020. Multiplexing primer/probe sets for detection of SARS-CoV-2 by qRT-PCR.
32526675 2020. AusDiagnostics SARS-CoV-2 kits shown to be more sensitive than reference laboratory test.
32361285 2020. Comparing the analytical performance of three SARS-CoV-2 molecular diagnostic assays.
32353760 2020. Comparison of the Panther Fusion and a laboratory-developed test targeting the envelope gene for detection of SARS-CoV-2.
32344319 2020. Ad hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samples.
32485473 2020. Evaluation of nCoV-QS (MiCo BioMed) for RT-qPCR detection of SARS-CoV-2 from nasopharyngeal samples using CDC FDA EUA qPCR kit as a gold standard: An example of the need of validation studies.
32474371 2020. Rapid implementation and validation of a cold-chain free SARS-CoV-2 diagnostic testing workflow to support surge capacity.
32460173 2020. Clinical evaluation of AusDiagnostics SARS-CoV-2 multiplex tandem PCR assay.
32425657 2020. Evaluation of the COVID19 ID NOW EUA assay.
32417674 2020. Multi-center evaluation of cepheid xpert(R) xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.
32416600 2020. Comparison of seven commercial RT-PCR diagnostic kits for COVID-19.
32405257 2020. Validation of SARS-CoV-2 detection across multiple specimen types.
32405254 2020. Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories.
32143123 2020. Rapid random access detection of the novel SARS-coronavirus-2 (SARS-CoV-2, previously 2019-nCoV) using an open access protocol for the Panther Fusion.
32381379 2020. Saliva samples as an alternative for novel coronavirus (COVID-19) diagnosis.
32446722 2020. Evaluation of a high-speed but low-throughput RT-qPCR system for SARS-CoV-2 detection.
32173458 2020. Experience of different upper respiratory tract sampling strategies for detection of COVID-19.
32474037 2020. Improved sensitivity using a dual target, E and RdRp assay for the diagnosis of SARS-CoV-2 infection: Experience at a large NHS Foundation Trust in the UK.
32474036 2020. Qualitative serology in patients recovered from SARS CoV 2 infection.
32473233 2020. Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive.
32473229 2020. Follow-up study on pulmonary function and radiological changes in critically ill patients with COVID-19.
32504740 2020. Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva.
32283141 2020. Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients.


32382737 2020. A Peptide-based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019 (COVID-19).
32534946 2020. Laboratory diagnosis of SARS-CoV-2 - A review of current methods.
32449329 2020. Clinical Significance of a High SARS-CoV-2 Viral Load in the Saliva.


32383182 2020. Should RT-PCR be considered a gold standard in the diagnosis of Covid-19?
32383179 2020. Comparison of SARS-CoV-2 detection from nasopharyngeal swab samples by the Roche cobas 6800 SARS-CoV-2 test and a laboratory-developed real-time RT-PCR test.
32369202 2020. Pooling of nasopharyngeal swab specimens for SARS-CoV-2 detection by RT-PCR.
32401374 2020. Prolonged SARS-Cov-2 RNA Detection in Anal/Rectal Swabs and Stool Specimens in COVID-19 Patients After Negative Conversion in Nasopharyngeal RT-PCR Test.
32401343 2020. Evaluating the efficiency of specimen pooling for PCR-based detection of COVID-19.
32219885 2020. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19.
32330297 2020. Optimization of group size in pool testing strategy for SARS-CoV-2: A simple mathematical model.
32513617 2020. In vitro diagnostics of coronavirus disease 2019: Technologies and application.
32405270 2020. Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Is Comparable in Clinical Samples Preserved in Saline or Viral Transport Medium.
32501315 2020. Au-decorated BN nanotube as a breathalyzer for potential medical applications.





32496708 2020. COVID-19 : quelle place, aujourd'hui, pour les tests serologiques ?
32536002 2020. Pitfalls in SARS-CoV-2 PCR diagnostics.
32526372 2020. Establishing a model for predicting the outcome of COVID-19 based on combination of laboratory tests.
32166939 2020. [Which sampling method for the upper respiratory tract specimen should be taken to diagnose patient with COVID-19?]

Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis